Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania

Autor: Anenmose Maro, Rehema, Mtenga, Alan, Mtesha, Benson, Wilhelm, Krisanta, Lekashingo, Naomi, Sumari-de Boer, Marion, Ngowi, Kennedy

Publikováno v: In Journal of Clinical Tuberculosis and Other Mycobacterial Diseases February 2024 34

Enhancing Tuberculosis Treatment Adherence: Evaluating the Efficacy of the Support for Treatment Adherence and Medication Protocols (STAMP) Device for Automatic Dispensing and Real-Time Medication Monitoring.

Autor: Jason Charles SC; Biostatistics, Sundaram Medical Devices Private Limited, Mylapore, IND., Anusha K; Research, Sundaram Medical Devices Private Limited, Mylapore, IND., Mahesh K; Biostatistics, Sundaram Medical Devices Private Limited, Mylapore, IND., Ramasubramanian R; Biostatistics, Sundaram Medical Devices Private Limited, Mylapore, IND., Kaliraj P; Biotechnology, Anna University, Chennai, IND., Selvaraj V; Applied Mechanics and Biomedical Engineering, Indian Institute of Technology Madras, Chennai, IND.

Publikováno v: Cureus [Cureus] 2024 Sep 17; Vol. 16 (9), pp. e69611. Date of Electronic Publication: 2024 Sep 17 (Print Publication: 2024).

Predicting viral load suppression by self-reported adherence, pharmacy refill counts and real time medication monitoring among people living with HIV in Tanzania

Autor: Kennedy M. Ngowi, Linda Minja, I. Marion Sumari-de Boer, Rob E. Aarnoutse, Lyidia Masika, Mirjam A. G. Sprangers, Francis M. Pima, Blandina T. Mmbaga, Peter Reiss, Pythia T. Nieuwkerk

Publikováno v: AIDS Research and Therapy, Vol 19, Iss 1, Pp 1-13 (2022)

Abstract Introduction Monitoring of adherence to antiretroviral treatment (ART) is of utmost importance to prevent treatment failure. Several measures to monitor adherence have been applied in low-resource settings and they all have pros and cons. Ou

Externí odkaz: https://doaj.org/article/53ce3e8428b3466b9cfb8f5d4fb428b9

Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania.

Autor: Anenmose Maro R; Kilimanjaro Clinical Research Institute, Moshi, Tanzania.; Nelson Mandela African Institute of Science and Technology, Arusha, Tanzania., Mtenga A; Kilimanjaro Clinical Research Institute, Moshi, Tanzania.; Nelson Mandela African Institute of Science and Technology, Arusha, Tanzania., Mtesha B; Kilimanjaro Clinical Research Institute, Moshi, Tanzania., Wilhelm K; Kilimanjaro Clinical Research Institute, Moshi, Tanzania., Lekashingo N; Kilimanjaro Clinical Research Institute, Moshi, Tanzania., Sumari-de Boer M; Kilimanjaro Clinical Research Institute, Moshi, Tanzania.; Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.; Kilimanjaro Christian Medical Univesity Collage, Moshi, Tanzania.; Knowledge, Innovation & Technology Group at Wageningen & University Research, the Netherlands., Ngowi K; Kilimanjaro Clinical Research Institute, Moshi, Tanzania.

Publikováno v: Journal of clinical tuberculosis and other mycobacterial diseases [J Clin Tuberc Other Mycobact Dis] 2023 Dec 03; Vol. 34, pp. 100409. Date of Electronic Publication: 2023 Dec 03 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.